0
Immuron Limited has reached its limit for free report views
Work for Immuron Limited? Upgrade Your Profile and unlock all your annual reports.
Immuron Limited
- 11-50 Employees
- Based in Melbourne, Australia
Immuron Ltd (ASX:IMC) (NASDAQ:IMRN) is a microbiome company focused on developing and commercialising oral immunotherapeutics for the treatment of many gut mediated diseases. Immuron has a unique and safe technology platform that enables a shorter development therapeutic cycle.
Immuron Limited
Most Recent Annual Report
MOST RECENT
2019 Annual Report
Report Locked. Immuron Limited has reached its limit for free report views.
